Phase I/IIa Clinical Trials

Early development decisions can better inform your late phase trials

With experience in 1,000+ early clinical studies, Quintiles can help you pursue the best path to proof of concept.


Assess safety, identify risks and set a sure course for development

Quintiles' Phase I/IIa scientists, project managers and clinical pharmacology units help you get the job done.

Phase I/IIa Clinical Trials
Phase I trials require facilities equipped with the latest medical technology while still offering healthy volunteers a safe, comfortable environment. Strategically located in Europe and the US, our Phase I units offer a comprehensive solution for your specific therapeutic area, geography, size and complexity.

We’ll help you: 

  • Develop novel methods to accelerate proof of concept.
  • Determine dose escalation and titration regimens.
  • Access our deep bench of scientific experts and full pharmacokinetic/pharmacodynamic (PK/PD) services.
  • Establish definitive QT and perform TQT analysis with the industry’s largest staff of cardiologists.
  • Adhere to globally consistent quality standards for patient safety and regulatory guidelines.

The power of possibilities

Related serivces

Early clinical development
Bioanalytical laboratories
Cardiac safety-ECG monitoring